← Open Payments lookup

BRENDA PRIMERO: Open Payments

NPI 1831613025 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,389 in 69 payments from 13 companies in 2025. Trend: 2023 $2,321 · 2024 $1,856 · 2025 $1,389

Food & beverage: $1,389
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.13$247
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$220
ABBVIE INC.10$204
Neurocrine BioSciences, Inc.7$185
Janssen Pharmaceuticals, Inc7$152
E.R. Squibb & Sons, L.L.C.10$149
Alkermes, Inc.3$65
Axsome Therapeutics, Inc.2$52
Takeda Pharmaceuticals U.S.A., Inc.2$38
Teva Pharmaceuticals USA, Inc.1$28

Products named: CAPLYTA, VRAYLAR, REXULTI, INGREZZA, COBENFY, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ARISTADA.

Industry payments across NV — which companies pay providers there.